Conservative Republican blowback continues to grow against a concept known as ESG investing, which takes environmental, social and corporate governance concerns into consideration when assessing the value of companies.
Indianapolis-based Rise Commercial District is part of a co-warehousing movement that provides small companies with flexible space as they grow, much like office co-working space does.
Indiana’s senior U.S. senator, Todd Young, a member of the Senate Foreign Relations Committee, recognized the need for America to lead in the innovation economy and the threat to our national security if we failed to do so.
Michele Sawyer started Sept. 1 as chief financial officer at the Indiana Biosciences Research Institute after more than two decades at drugmaker Eli Lilly and Co. and its animal health spinoff, Elanco Animal Health.
Humankind is a software-as-a-service company whose platform allows retailers to make personal connections with online shoppers. Indianapolis-based venture studio launched the company last fall, and it now has 16 employees.
Duke Realty Corp.’s legacy will linger beyond its pending $26 billion all-stock acquisition by industrial-sector behemoth Prologis Inc., expected to close early next month.
Abby Vitale’s struggle to find sneakers she liked in a woman’s size 7 last year at a shoe resellers’ convention has led to a growing business and has established an online community for female sneakerheads.
Driven by frustration with “Big Tech,” the bills bar innovative tech firms from selling inexpensive, private-label products and from bundling services, such as free shipping, in ways that help consumers.
The software company Unbox says it plans to establish its U.S. headquarters in Indianapolis as well as a software development, research and testing hub in West Lafayette. The company said it hopes to have up to 380 Indiana employees within the next few years.
Reporters and newsroom staff today are being asked to carry the same workload three or four folks might have carried back in the late 1990s or early 2000s.
Indianapolis-based biotech firm Point Biopharma Global Inc. hopes to raise about $125 million in the offering, before underwriting expenses and deductions.
